Three genes (ARNTL, ARNTL2, BHLHE40) from MDSet (six merged datasets) could represent unfavorable prognostic factors for GBM, whereas CRY2, DBP and NR1D2 were associated with better prognosis (Figure 1A). Here, CRY2 is linked to glioblastoma.